H2O AM’s Alexion Pharmaceuticals ALXN Stock Holding History

H2O AM’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-25,000	Closed	-$2.45M	–	106
2019 Q3	$2.45M	Buy	+25,000	New	+$2.82M	0.42%	52

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

H2O AM's ALXN Position: Q4 2019 in Review

H2O AM sold out of Alexion Pharmaceuticals (ALXN) in Q4 2019, closing a stake of 25,000 shares — an estimated $2.45M sold.

H2O AM first reported a position in ALXN in Q3 2019 and held it in 1 quarter. The position peaked at $2.45M in Q3 2019. 669 funds tracked by Wall St. Rank hold ALXN as of Q4 2019.

H2O AM reported no remaining Alexion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
H2O AM sold 25,000 Alexion Pharmaceuticals shares in Q4 2019, an estimated $2.45M.
H2O AM first reported a position in Alexion Pharmaceuticals in Q3 2019 and held it in 1 quarter.
H2O AM's Alexion Pharmaceuticals position peaked at $2.45M in Q3 2019.
669 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2019.

Based on H2O AM's 13F filing for Q4 2019, filed 14 Feb 2020.